Trials / Completed
CompletedNCT04018846
The Future of Revascularization Using a Bioprotec Graft
The Future of the Revascularization Using a Bioprotec Graft
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Hôpital NOVO · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is the rate assessment of rescued limbs, one year after a BIOPROTEC vascular graft.
Detailed description
The BIOPROTEC grafts are controverted: they are useful in some cases, but they are known as frequently broken or thrombosed. However they are always posed in a complicated situations, in a fragile patients who have ever had many of revascularizations or in an infectious state (which is supportive of the pseudoaneurysm and thrombosis) Despite the frequent use of this graft in France, the results have never been published.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Revascularization using a BIOPROTEC Graft | It is about a routine care study not changing the usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular Doctor in 1 month, 6 months, 12 months, 18 months and 2 years. |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-10-07
- Completion
- 2022-10-07
- First posted
- 2019-07-15
- Last updated
- 2024-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04018846. Inclusion in this directory is not an endorsement.